{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Biopsies&page=11", "query": { "intervention": "Biopsies", "page": 11 }, "page_size": 10 }, "pagination": { "page": 11, "page_size": 10, "total_count": 3745, "total_pages": 375, "next_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Biopsies&page=12&page_size=10", "previous_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Biopsies&page=10&page_size=10" }, "source": "remote", "last_synced_at": "2026-10-25T03:07:35.012Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT05950113", "title": "CART-BCMA/CS1 in Treating Patients With Relapsed or Refractory Multiple Myeloma", "overall_status": "WITHDRAWN", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Recurrent Multiple Myeloma", "Refractory Multiple Myeloma" ], "interventions": [ { "name": "Bone Marrow Aspiration", "type": "PROCEDURE" }, { "name": "Bone Marrow Biopsy", "type": "PROCEDURE" }, { "name": "Computed Tomography", "type": "PROCEDURE" }, { "name": "Cyclophosphamide", "type": "DRUG" }, { "name": "Echocardiography", "type": "PROCEDURE" }, { "name": "Fludarabine", "type": "DRUG" }, { "name": "Fludeoxyglucose F-18", "type": "OTHER" }, { "name": "Immunotherapy", "type": "OTHER" }, { "name": "Leukapheresis", "type": "PROCEDURE" }, { "name": "Magnetic Resonance Imaging", "type": "PROCEDURE" }, { "name": "Positron Emission Tomography", "type": "PROCEDURE" } ], "intervention_types": [ "PROCEDURE", "DRUG", "OTHER" ], "sponsor": "Jonsson Comprehensive Cancer Center", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "74 Years", "sex": "ALL", "summary": "18 Years to 74 Years" }, "enrollment_count": 0, "start_date": "2024-03-28", "completion_date": "2028-03-28", "has_results": false, "last_update_posted_date": "2024-05-01", "last_synced_at": "2026-10-25T03:07:35.012Z", "location_count": 1, "location_summary": "Los Angeles, California", "locations": [ { "city": "Los Angeles", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT05950113" }, { "nct_id": "NCT05872503", "title": "Study of Rates of Prostate Cancer Diagnosis in Men of African Ancestry Using MRI and MRI Guided Biopsy", "overall_status": "TERMINATED", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Prostate Specific Antigens", "Positive Digital Rectal Examination", "Strong Family History of Prostate Cancer", "Prostatic Neoplasms" ], "interventions": [], "intervention_types": [], "sponsor": "National Cancer Institute (NCI)", "sponsor_class": "NIH", "healthy_volunteers": false, "eligibility": { "minimum_age": "35 Years", "maximum_age": "120 Years", "sex": "MALE", "summary": "35 Years to 120 Years · Male only" }, "enrollment_count": 3, "start_date": "2024-03-20", "completion_date": "2024-09-10", "has_results": false, "last_update_posted_date": "2025-07-10", "last_synced_at": "2026-10-25T03:07:35.012Z", "location_count": 1, "location_summary": "Bethesda, Maryland", "locations": [ { "city": "Bethesda", "state": "Maryland" } ], "official_url": "https://clinicaltrials.gov/study/NCT05872503" }, { "nct_id": "NCT05917522", "title": "Assessment of Biomarker-Guided CNI Substitution In Kidney Transplantation", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Kidney Transplant" ], "interventions": [ { "name": "Abatacept", "type": "BIOLOGICAL" }, { "name": "Standard of Care at US Transplant Centers", "type": "PROCEDURE" } ], "intervention_types": [ "BIOLOGICAL", "PROCEDURE" ], "sponsor": "National Institute of Allergy and Infectious Diseases (NIAID)", "sponsor_class": "NIH", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "70 Years", "sex": "ALL", "summary": "18 Years to 70 Years" }, "enrollment_count": 800, "start_date": "2023-12-07", "completion_date": "2029-07", "has_results": false, "last_update_posted_date": "2026-03-23", "last_synced_at": "2026-10-25T03:07:35.012Z", "location_count": 15, "location_summary": "Birmingham, Alabama • Los Angeles, California • New Haven, Connecticut + 11 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Los Angeles", "state": "California" }, { "city": "Los Angeles", "state": "California" }, { "city": "New Haven", "state": "Connecticut" }, { "city": "Baltimore", "state": "Maryland" } ], "official_url": "https://clinicaltrials.gov/study/NCT05917522" }, { "nct_id": "NCT02197351", "title": "Narrow Band Imaging for Gastric Neoplasia", "overall_status": "UNKNOWN", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Gastric Cancer", "Gastric Metaplasia", "Gastric Dysplasia" ], "interventions": [ { "name": "White light biopsy", "type": "PROCEDURE" }, { "name": "Protocolled", "type": "PROCEDURE" }, { "name": "Narrow Band Imaging Guided Biopsy", "type": "PROCEDURE" } ], "intervention_types": [ "PROCEDURE" ], "sponsor": "University of Southern California", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 220, "start_date": "2014-07", "completion_date": "2023-12", "has_results": false, "last_update_posted_date": "2023-03-06", "last_synced_at": "2026-10-25T03:07:35.012Z", "location_count": 1, "location_summary": "Los Angeles, California", "locations": [ { "city": "Los Angeles", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT02197351" }, { "nct_id": "NCT00622895", "title": "Allogeneic Hematopoietic Cell Transplantation for Severe Systemic Sclerosis", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1", "PHASE2" ], "conditions": [ "Systemic Scleroderma", "Severe Systemic Sclerosis" ], "interventions": [ { "name": "fludarabine phosphate", "type": "DRUG" }, { "name": "Mycophenolic Acid", "type": "DRUG" }, { "name": "tacrolimus", "type": "DRUG" }, { "name": "total-body irradiation", "type": "RADIATION" }, { "name": "bone marrow transplantation", "type": "PROCEDURE" }, { "name": "reduced intensity allogeneic hematopoietic stem cell transplantation", "type": "PROCEDURE" }, { "name": "quality-of-life assessment", "type": "PROCEDURE" }, { "name": "laboratory biomarker analysis", "type": "OTHER" }, { "name": "flow cytometry", "type": "OTHER" }, { "name": "biopsy", "type": "PROCEDURE" } ], "intervention_types": [ "DRUG", "RADIATION", "PROCEDURE", "OTHER" ], "sponsor": "Fred Hutchinson Cancer Center", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": null, "maximum_age": "70 Years", "sex": "ALL", "summary": "Up to 70 Years" }, "enrollment_count": 3, "start_date": "2006-09-01", "completion_date": "2017-08-01", "has_results": true, "last_update_posted_date": "2018-06-04", "last_synced_at": "2026-10-25T03:07:35.012Z", "location_count": 2, "location_summary": "Denver, Colorado • Seattle, Washington", "locations": [ { "city": "Denver", "state": "Colorado" }, { "city": "Seattle", "state": "Washington" } ], "official_url": "https://clinicaltrials.gov/study/NCT00622895" }, { "nct_id": "NCT02988388", "title": "Lung Tissue Research Consortium", "overall_status": "COMPLETED", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Chronic Obstructive Pulmonary Disease", "Interstitial Lung Disease" ], "interventions": [ { "name": "Lung biopsy/lobectomy", "type": "PROCEDURE" } ], "intervention_types": [ "PROCEDURE" ], "sponsor": "National Heart, Lung, and Blood Institute (NHLBI)", "sponsor_class": "NIH", "healthy_volunteers": true, "eligibility": { "minimum_age": "21 Years", "maximum_age": null, "sex": "ALL", "summary": "21 Years and older" }, "enrollment_count": 247, "start_date": "2017-02-23", "completion_date": "2019-02-21", "has_results": false, "last_update_posted_date": "2019-03-08", "last_synced_at": "2026-10-25T03:07:35.012Z", "location_count": 4, "location_summary": "Ann Arbor, Michigan • Rochester, Minnesota • Philadelphia, Pennsylvania + 1 more", "locations": [ { "city": "Ann Arbor", "state": "Michigan" }, { "city": "Rochester", "state": "Minnesota" }, { "city": "Philadelphia", "state": "Pennsylvania" }, { "city": "Pittsburgh", "state": "Pennsylvania" } ], "official_url": "https://clinicaltrials.gov/study/NCT02988388" }, { "nct_id": "NCT05424783", "title": "MRI And GPS Informing Choices for Prostate Cancer Treatment (MAGIC)", "overall_status": "ACTIVE_NOT_RECRUITING", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Prostate Cancer" ], "interventions": [ { "name": "Genomic Prostate Score assay and Multi-parametric magnetic resonance imaging study of the prostate", "type": "OTHER" } ], "intervention_types": [ "OTHER" ], "sponsor": "Northwestern University", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "40 Years", "maximum_age": "76 Years", "sex": "MALE", "summary": "40 Years to 76 Years · Male only" }, "enrollment_count": 222, "start_date": "2022-10-15", "completion_date": "2027-02-01", "has_results": false, "last_update_posted_date": "2026-08-19", "last_synced_at": "2026-10-25T03:07:35.012Z", "location_count": 2, "location_summary": "Chicago, Illinois", "locations": [ { "city": "Chicago", "state": "Illinois" }, { "city": "Chicago", "state": "Illinois" } ], "official_url": "https://clinicaltrials.gov/study/NCT05424783" }, { "nct_id": "NCT03178851", "title": "Cobimetinib (Targeted Therapy) Plus Atezolizumab (Immunotherapy) in Participants With Advanced Melanoma Whose Cancer Has Worsened During or After Treatment With Previous Immunotherapy and Atezolizumab Monotherapy in Participants With Previously Untreated Advanced Melanoma", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Malignant Melanoma" ], "interventions": [ { "name": "Atezolizumab", "type": "BIOLOGICAL" }, { "name": "Cobimetinib", "type": "DRUG" } ], "intervention_types": [ "BIOLOGICAL", "DRUG" ], "sponsor": "Hoffmann-La Roche", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 155, "start_date": "2017-06-20", "completion_date": "2020-09-21", "has_results": true, "last_update_posted_date": "2021-11-19", "last_synced_at": "2026-10-25T03:07:35.012Z", "location_count": 6, "location_summary": "Scottsdale, Arizona • Aurora, Colorado • Detroit, Michigan + 3 more", "locations": [ { "city": "Scottsdale", "state": "Arizona" }, { "city": "Aurora", "state": "Colorado" }, { "city": "Detroit", "state": "Michigan" }, { "city": "St Louis", "state": "Missouri" }, { "city": "Nashville", "state": "Tennessee" } ], "official_url": "https://clinicaltrials.gov/study/NCT03178851" }, { "nct_id": "NCT07682831", "title": "Machine Learning Analysis of Two-photon Fluorescence Microscopy of Dermatologic Biopsies", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Basal Cell Carcinoma of Skin", "Squamous Cell Carcinoma (Skin)" ], "interventions": [ { "name": "Two photon microscopy imaging", "type": "DEVICE" } ], "intervention_types": [ "DEVICE" ], "sponsor": "University of Rochester", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": null, "maximum_age": null, "sex": "ALL", "summary": "Not listed" }, "enrollment_count": 92, "start_date": "2026-06-24", "completion_date": "2027-07-01", "has_results": false, "last_update_posted_date": "2026-08-19", "last_synced_at": "2026-10-25T03:07:35.012Z", "location_count": 1, "location_summary": "Victor, New York", "locations": [ { "city": "Victor", "state": "New York" } ], "official_url": "https://clinicaltrials.gov/study/NCT07682831" }, { "nct_id": "NCT04051242", "title": "Enhanced Bioscaffold for Volumetric Muscle Loss", "overall_status": "TERMINATED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Muscle Loss" ], "interventions": [ { "name": "XenMatrix™ AB Surgical Graft", "type": "DEVICE" } ], "intervention_types": [ "DEVICE" ], "sponsor": "J. Peter Rubin, MD", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "70 Years", "sex": "ALL", "summary": "18 Years to 70 Years" }, "enrollment_count": 10, "start_date": "2020-02-10", "completion_date": "2024-01-24", "has_results": true, "last_update_posted_date": "2025-04-25", "last_synced_at": "2026-10-25T03:07:35.012Z", "location_count": 1, "location_summary": "Pittsburgh, Pennsylvania", "locations": [ { "city": "Pittsburgh", "state": "Pennsylvania" } ], "official_url": "https://clinicaltrials.gov/study/NCT04051242" } ] }